WO2008134674A1 - Uv-absorbers for ophthalmic lens materials - Google Patents

Uv-absorbers for ophthalmic lens materials Download PDF

Info

Publication number
WO2008134674A1
WO2008134674A1 PCT/US2008/061844 US2008061844W WO2008134674A1 WO 2008134674 A1 WO2008134674 A1 WO 2008134674A1 US 2008061844 W US2008061844 W US 2008061844W WO 2008134674 A1 WO2008134674 A1 WO 2008134674A1
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic device
disubstituted
device material
formula
triazole compound
Prior art date
Application number
PCT/US2008/061844
Other languages
French (fr)
Inventor
Douglas C. Schlueter
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Priority to DE602008002426T priority Critical patent/DE602008002426D1/en
Priority to AU2008245533A priority patent/AU2008245533B2/en
Priority to JP2010506567A priority patent/JP5273748B2/en
Priority to CA2683002A priority patent/CA2683002C/en
Priority to AT08747077T priority patent/ATE479664T1/en
Priority to EP08747077A priority patent/EP2139871B1/en
Publication of WO2008134674A1 publication Critical patent/WO2008134674A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms

Definitions

  • This invention is directed to ultraviolet light absorbers.
  • this invention relates to 1 ,4-disubstituted-1 ,2,3-triazole UV light absorbing monomers.
  • UV light absorbers are known as ingredients for polymeric materials used to make ophthalmic lenses. UV absorbers are preferably covalently bound to the polymeric network of the lens material instead of simply physically entrapped in the material to prevent the absorber from migrating, phase separating or leaching out of the lens material. Such stability is particularly important for implantable ophthalmic lenses where the leaching of the UV absorber may present both toxicological issues and lead to the loss of UV blocking activity in the implant.
  • UV absorbers Numerous copolymerizable benzatriazole, benzophenone and triazine UV absorbers are known. Many of these UV absorbers contain conventional olefinic polymerizable groups, such as methacrylate, acrylate, methacrylamide, acrylamide or styrene groups. Copolymerization with other ingredients in the lens materials, typically with a radical initiator, incorporates the UV absorbers into the resulting polymer chain. Incorporation of additional functional groups, on a UV absorber may influence one or more of the UV absorber's UV absorbing properties, solubility or reactivity.
  • the UV absorber may coalesce into domains that could interact with light and result in decreased optical clarity of the lens.
  • Examples of polymeric ophthalmic lens materials that incorporate UV absorbers can be found in U.S. Patent Nos. 5,290,892; 5,331 ,073 and 5,693,095.
  • the present invention provides 1 ,4-disubstituted-1 ,2,3-triazole UV light absorbing monomers. These UV absorbers are suitable for use in ophthalmic lenses, including contact lenses. They are particularly useful in implantable lenses, such as intraocular lenses (1OLs).
  • UV absorbers of the present invention are represented by the formula
  • x is 1 - 12;
  • Y is H, CH 3 , CH 2 OH, or CH 3 CH 2 ;
  • Z is O, NH, N(CH 3 ), or N(CH 2 CH 3 );
  • Z' is O, NH, N(CH 3 ), or N(CH 2 CH 3 );
  • R" is H, F, Cl, Br, I 1 O(CH 2 ) X H, NH 2 , NH(CH 3 ), N(CH 3 ) 2 , CH 3 , CH 2 CH 3 ,
  • Preferred UV absorbers of the present invention are those of formulas [1] - [3]:
  • x is 1 - 12;
  • Z is O, NH, N(CH 3 ), or N(CH 2 CH 3 ); and R 2 is H, F, Cl, Br, I, O(CH 2 ) X H, NH 2 , NH(CH 3 ), N(CH 3 ) 2 , CH 3 , CH 2 CH 3 , CH(CHs) 2 , C(CH 3 ) 3 , C 6 H 5 , or OC 6 H 5 ;
  • R 3 is H, F, Cl, Br, I, O(CH 2 ) X H, NH 2 , NH(CH 3 ), N(CH 3 ) 2 , CH 3 , CH 2 CH 3 , CH(CH 3 ) 2 , C(CHs) 3 , C 6 H 5 , or OC 6 H 5 ;
  • x is 1 - 12;
  • Y is H, CH 3 , or CH 3 CH 2 ; and Z is O, NH, N(CH 3 ), or N(CH 2 CH 3 );
  • R 6 is H, F, Cl 1 Br, I 1 O(CH 2 ) X H, NH 2 , NH(CH 3 ), N(CH 3 ) 2 , CH 3 , CH 2 CH 3 ,
  • Z is O 1 NH, N(CH 3 ), N(CH 2 CH 3 ), or nothing;
  • an aliphatic azide is coupled with an o- alkynylphenol in a single step to produce the target phenyl substituted 1 ,2,3- triazole where the placement of the phenol group next to the triazole is considered for desired UV absorbance characteristics.
  • azidoethyl methacrylate with 2-ethynyl-phenol will produce a 1 ,2,3-triazole functional polymerizable UV absorber in a single step.
  • Additional hydroxyl functionality is envisioned through use of propanediol or glycerol based aliphatic azides.
  • Scheme 2 presents the combination of a substituted phenolic azide and an aliphatic alkyne.
  • a substituted phenolic azide for example, coupling of propargyl methacrylate with o-azidophenol in the presence of CuBr will result in the target triazole functional polymerizable UV absorber.
  • both aromatic radicals for example, propargyl methacrylate with o-azidophenol in the presence of CuBr will result in the target triazole functional polymerizable UV absorber.
  • I 5 from aromatic azide and aliphatic alkyne.
  • the UV absorbers of the present invention are particularly suitable for use in 1OLs.
  • IOL materials will generally contain from 0.1 to 5 % (w/w) of a UV absorber of the present invention.
  • IOL materials will contain from 0.5 to 3 % (w/w) of a UV absorber of the present invention.
  • Such device materials are prepared by copolymerizing the UV absorbers of the present invention with other ingredients, such as device-forming materials, cross- linking agents, and blue-light blocking chromophores.
  • any known IOL device material is suitable for use in the compositions of the present invention.
  • the ophthalmic device materials comprise an acrylic or methacrylic device-forming monomer. More preferably, the device-forming monomers comprise a monomer of formula [IV]:
  • A is H, CH 3 , CH 2 CH 3 , or CH 2 OH;
  • B is (CH 2 ) m or [O(CH 2 ) 2 ] Z ;
  • C is (CH 2 ) W ;
  • m is 2 - 6;
  • z is 1 - 10;
  • Y is nothing, O, S, or NR', provided that if Y is O, S, or NR', then
  • B is (CH 2 ) m ;
  • D is H, Ci - C 4 alkyl, Ci - C 4 alkoxy, C 6 H 5 , CH 2 C 6 H 5 or halogen.
  • Preferred monomers of formula [IV] are those wherein A is H or CH 3 , B is (CH 2 ) m , m is 2 - 5, Y is nothing or O, w is O - 1 , and D is H. Most preferred are 2-phenylethyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-benzyloxyethyl methacrylate; and 3-benzyloxypropyl methacrylate;and their corresponding acrylates.
  • Monomers of formula [IV] are known and can be made by known methods.
  • the conjugate alcohol of the desired monomer can be combined in a reaction vessel with methyl methacrylate, tetrabutyl titanate
  • Device materials generally comprise a total of at least about 75%, preferably at least about 80%, of device-forming monomers.
  • the device materials of the present invention generally comprise a cross-linking agent.
  • the cross-linking agent used in the device materials of this invention may be any terminally ethylenically unsaturated compound having more than one unsaturated group.
  • the total amount of the cross-linking component is at least
  • 0.1 % by weight and, depending on the identity and concentration of the remaining components and the desired physical properties, can range to about 20% by weight.
  • the preferred concentration range for the cross-linking component is 0.1 - 17% (w/w).
  • Suitable polymerization initiators for device materials containing a UV absorber of the present invention include thermal initiators and photoinitiators.
  • Preferred thermal initiators include peroxy free-radical initiators, such as t-butyl (peroxy-2-ethyl)hexanoate and di-(tert-butylcyclohexyl) peroxydicarbonate (commercially available as Perkadox ® 16 from Akzo Chemicals Inc., Chicago, Illinois). Initiators are typically present in an amount of about 5% (w/w) or less. Because free-radical initiators do not become chemically a part of the polymers formed, the total amount of initiator is customarily not included when determining the amounts of other ingredients.
  • the device materials containing a UV absorber of the present invention preferably also contain a reactive colorant.
  • Suitable reactive blue-light absorbing compounds include those described in U.S. Patent No. 5,470,932. Blue-light absorbers are typically present in an amount from about 0.01 - 0.5 % (weight).
  • the IOLs constructed of the materials of the present invention can be of any design capable of being rolled or folded into a small cross section that can fit through a relatively smaller incision.
  • the IOLs can be of what is known as a one piece or multipiece design, and comprise optic and haptic components.
  • the optic is that portion which serves as the lens.
  • the haptics are attached to the optic and hold the optic in its proper place in the eye.
  • the optic and haptic(s) can be of the same or different material.
  • a multipiece lens is so called because the optic and the haptic(s) are made separately and then the haptics are attached to the optic.
  • the optic and the haptics are formed out of one piece of material. Depending on the material, the haptics are then cut, or lathed, out of the material to produce the 1OL.
  • the materials of the present invention are also suitable for use in other ophthalmic devices, such as contact lenses, keratoprostheses, and corneal inlays or rings.
  • a 100 ml round bottom flask containing a PTFE coated stir bar is charged with 3.1Og of azido ethyl methacrylate (20 mmol), 2.36 g of o-hydroxyphenyl acetylene (20 mmol) and 50 mL of tetrahydrofuran. Copper turnings (1 g) were weighed and added. The flask was closed with a glass stopper and the reaction was stirred 48 h at ambient temperature. The copper was removed and the solvent was evaporated to yield product UV-1.
  • a 100 ml round bottom flask containing a PTFE coated stir bar is charged with 5.09 g of 3-azido-2-azidomethyl-2-hydroxymethyl-propyl methacrylate (20 mmol), 2.36 g of o-hydroxyphenyl acetylene (20 mmol) and 50 ml_ of tetrahydrofuran. Copper turnings (1 g) are added and the solution is stirred for 48 h at ambient temperature. The copper was removed and the solvent was evaporated to yield product UV-2.
  • a 100 ml round bottom flask containing a PTFE coated stir bar is flushed with N2 and charged with 2.48 g of propargyl methacrylate (20 mmol), 2.70 g of 2- azidophenol (20 mmol), 50 ml_ of N,N-dimethylformamide, 3.54 g of N 1 N 1 N 1 N", N"-pentamethyldiethylenetriamine, and 2.87 g of CuBr .
  • the solution is stirred for 24 h at ambient temperature under a N 2 blanket.
  • the reaction mixture is then exposed to air and purified by passing through a chromatographic alumina column. The eluent is collected and the solvent is evaporated to yield product UV-3.
  • a vial is charged with ingredients as listed in Table 1 except for the initiator.
  • the solution is mixed thoroughly and de-gassed by bubbling with N 2 .
  • the initiator is added and the solution is again mixed thoroughly.
  • the solution is filtered through a 0.2 micron PTFE filter and transferred to polypropylene molds.
  • the molds are heated in a mechanical convection oven at 70 0 C for 1 hr, then 110 0 C for 2 hrs.
  • the resulting copolymer samples are removed from the polypropylene molds and extracted in refluxing acetone for at least 3 hr, then rinsed with fresh acetone and allowed to air dry.
  • the extracted polymer is dried under vacuum at 70 0 C for at least 3 hr.
  • PEA 2-phenylethyl acrylate
  • PBMA 4-phenylbutyl methacrylate
  • HEMA 2-hydroxyethyl methacrylate
  • PEG(1000)DMA polyethylene glycol (1000) dimethacrylate
  • EGDMA ethylene glycol dimethacrylate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Eyeglasses (AREA)
  • Optical Filters (AREA)
  • Prostheses (AREA)

Abstract

1,4-disubstituted-1,2,3-triazole UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.

Description

UV-ABSORBERS FOR OPHTHALMIC LENS MATERIALS
Field of the Invention
This invention is directed to ultraviolet light absorbers. In particular, this invention relates to 1 ,4-disubstituted-1 ,2,3-triazole UV light absorbing monomers.
Background of the Invention
Many UV light absorbers are known as ingredients for polymeric materials used to make ophthalmic lenses. UV absorbers are preferably covalently bound to the polymeric network of the lens material instead of simply physically entrapped in the material to prevent the absorber from migrating, phase separating or leaching out of the lens material. Such stability is particularly important for implantable ophthalmic lenses where the leaching of the UV absorber may present both toxicological issues and lead to the loss of UV blocking activity in the implant.
Numerous copolymerizable benzatriazole, benzophenone and triazine UV absorbers are known. Many of these UV absorbers contain conventional olefinic polymerizable groups, such as methacrylate, acrylate, methacrylamide, acrylamide or styrene groups. Copolymerization with other ingredients in the lens materials, typically with a radical initiator, incorporates the UV absorbers into the resulting polymer chain. Incorporation of additional functional groups, on a UV absorber may influence one or more of the UV absorber's UV absorbing properties, solubility or reactivity. If the UV absorber does not have sufficient solubility in the remainder of the ophthalmic lens material ingredients or polymeric lens material, the UV absorber may coalesce into domains that could interact with light and result in decreased optical clarity of the lens. Examples of polymeric ophthalmic lens materials that incorporate UV absorbers can be found in U.S. Patent Nos. 5,290,892; 5,331 ,073 and 5,693,095.
Summary of the Invention
The present invention provides 1 ,4-disubstituted-1 ,2,3-triazole UV light absorbing monomers. These UV absorbers are suitable for use in ophthalmic lenses, including contact lenses. They are particularly useful in implantable lenses, such as intraocular lenses (1OLs).
Detailed Description of the Invention
Unless indicated otherwise, all ingredient amounts expressed in percentage terms are presented as % w/w.
The UV absorbers of the present invention are represented by the formula
•N'%
R1
where
O O
/Λ_icH - Y| Z-CH2CH(°H)CH2- γγS-(cH2)x-
R is
Figure imgf000003_0001
, or
Figure imgf000004_0001
x is 1 - 12;
Y is H, CH3, CH2OH, or CH3CH2;
Z is O, NH, N(CH3), or N(CH2CH3);
Z' is O, NH, N(CH3), or N(CH2CH3);
R" is H, F, Cl, Br, I1 O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3,
CH(CH3)2, C(CH3)3, C6H5, or OC6H5; and
R"' is CH2=CH-, CH2=(CH3)-, or
Figure imgf000004_0002
provided that one, but not both, of R and R' is
Figure imgf000004_0003
Preferred UV absorbers of the present invention are those of formulas [1] - [3]:
Figure imgf000004_0004
[1 ] where in formula [1]
Figure imgf000005_0001
x is 1 - 12;
Y iS H1 CH31 Or CH3CH2; Z is O, NH, N(CH3), or N(CH2CH3); and R2 is H, F, Cl, Br, I, O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3, CH(CHs)2, C(CH3)3, C6H5, or OC6H5;
Figure imgf000005_0002
[2] where in formula [2]
R3 is H, F, Cl, Br, I, O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3, CH(CH3)2, C(CHs)3, C6H5, or OC6H5;
Figure imgf000005_0003
x is 1 - 12;
Y is H, CH3, or CH3CH2; and Z is O, NH, N(CH3), or N(CH2CH3); and
Figure imgf000006_0001
[3] where in formula [3]
R5 is CH2=CH-, CH2=C(CH3)-, or
Figure imgf000006_0002
R6 is H, F, Cl1 Br, I1 O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3,
CH(CH3)2, C(CHs)3, C6H5, or OC6H5; x is 0-12;
Y iS H1 CH3, Or CH3CH2;
Z is O1 NH, N(CH3), N(CH2CH3), or nothing; and
Z' is O, NH, N(CH3), N(CH2CH3), or nothing; provided that if x is O, then Z ≠ nothing and Z' = nothing.
The synthesis of the UV absorbers of the present invention is described below. In Scheme 1 , an aliphatic azide is coupled with an o- alkynylphenol in a single step to produce the target phenyl substituted 1 ,2,3- triazole where the placement of the phenol group next to the triazole is considered for desired UV absorbance characteristics. For example, azidoethyl methacrylate with 2-ethynyl-phenol will produce a 1 ,2,3-triazole functional polymerizable UV absorber in a single step. Additional hydroxyl functionality is envisioned through use of propanediol or glycerol based aliphatic azides.
Figure imgf000007_0001
Scheme 1. Synthesis of 1 ,2,3-triazole functional polymerizable UV absorbers from aliphatic azide and aromatic alkyne.
Alternatively, the structural functionalities in the synthetic scheme may be reversed. Scheme 2 presents the combination of a substituted phenolic azide and an aliphatic alkyne. For example, coupling of propargyl methacrylate with o-azidophenol in the presence of CuBr will result in the target triazole functional polymerizable UV absorber. Further, both aromatic
10 azides and aromatic alkyne structures are envisioned as shown in Scheme 3.
N3
(a)
OH -O \ N N^=N R OH
Figure imgf000007_0002
Scheme 2. Synthesis of 1 ,2,3-triazole functional polymerizable UV absorbers
I5 from aromatic azide and aliphatic alkyne.
Figure imgf000008_0001
Scheme 3. Synthesis of 1,2,3-triazole functional polymerizable UV absorbers from aromatic azide and aromatic alkyne.
The UV absorbers of the present invention are particularly suitable for use in 1OLs. IOL materials will generally contain from 0.1 to 5 % (w/w) of a UV absorber of the present invention. Preferably, IOL materials will contain from 0.5 to 3 % (w/w) of a UV absorber of the present invention. Such device materials are prepared by copolymerizing the UV absorbers of the present invention with other ingredients, such as device-forming materials, cross- linking agents, and blue-light blocking chromophores.
Many device-forming monomers are known in the art and include both acrylic and silicone-containing monomers among others. See, for example,
U.S. Nos. 7,101 ,949; 7,067,602; 7,037,954; 6,872,793 6,852,793; 6,846,897;
6,806,337; 6,528,602; and 5,693,095. In the case of lOLs, any known IOL device material is suitable for use in the compositions of the present invention. Preferably, the ophthalmic device materials comprise an acrylic or methacrylic device-forming monomer. More preferably, the device-forming monomers comprise a monomer of formula [IV]:
Figure imgf000008_0002
[IV] where in formula [IV]: A is H, CH3, CH2CH3, or CH2OH; B is (CH2)m or [O(CH2)2]Z; C is (CH2)W; m is 2 - 6; z is 1 - 10;
Y is nothing, O, S, or NR', provided that if Y is O, S, or NR', then
B is (CH2)m; R' is H, CH3, Cn-H2n'+1 (n'=1-10), iso-OC3H7, C6H5, or
CH2C6H5; w is O - 6, provided that m + w <8; and
D is H, Ci - C4 alkyl, Ci - C4 alkoxy, C6H5, CH2C6H5 or halogen.
Preferred monomers of formula [IV] are those wherein A is H or CH3, B is (CH2)m, m is 2 - 5, Y is nothing or O, w is O - 1 , and D is H. Most preferred are 2-phenylethyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-benzyloxyethyl methacrylate; and 3-benzyloxypropyl methacrylate;and their corresponding acrylates.
Monomers of formula [IV] are known and can be made by known methods. For example, the conjugate alcohol of the desired monomer can be combined in a reaction vessel with methyl methacrylate, tetrabutyl titanate
(catalyst), and a polymerization inhibitor such as 4-benzyloxy phenol. The vessel can then be heated to facilitate the reaction and distill off the reaction by-products to drive the reaction to completion. Alternative synthesis schemes involve adding methacrylic acid to the conjugate alcohol and catalyzing with a carbodiimide or mixing the conjugate alcohol with methacryloyl chloride and a base such as pyridine or triethylamine.
Device materials generally comprise a total of at least about 75%, preferably at least about 80%, of device-forming monomers. In addition to a UV absorber of the present invention and a device- forming monomer, the device materials of the present invention generally comprise a cross-linking agent. The cross-linking agent used in the device materials of this invention may be any terminally ethylenically unsaturated compound having more than one unsaturated group. Suitable cross-linking agents include, for example: ethylene glycol dimethacrylate; diethylene glycol dimethacrylate; allyl methacrylate; 1 ,3-propanediol dimethacrylate; 2,3- propanediol dimethacrylate; 1 ,6-hexanediol dimethacrylate; 1 ,4-butanediol dimethacrylate; CH2=C(CH3)C(=O)O-(CH2CH2θ)p-C(=O)C(CH3)=CH2 where p = 1 - 50; and CH2=C(CH3)C(=O)O(CH2)tO-C(=O)C(CH3)=CH2 where t = 3 - 20; and their corresponding acrylates. A preferred cross-linking monomer is CH2=C(CH3)C(=O)O-(CH2CH2θ)p-C(=O)C(CH3)=CH2 where p is such that the number-average molecular weight is about 400, about 600, or about 1000.
Generally, the total amount of the cross-linking component is at least
0.1 % by weight and, depending on the identity and concentration of the remaining components and the desired physical properties, can range to about 20% by weight. The preferred concentration range for the cross-linking component is 0.1 - 17% (w/w).
Suitable polymerization initiators for device materials containing a UV absorber of the present invention include thermal initiators and photoinitiators. Preferred thermal initiators include peroxy free-radical initiators, such as t-butyl (peroxy-2-ethyl)hexanoate and di-(tert-butylcyclohexyl) peroxydicarbonate (commercially available as Perkadox® 16 from Akzo Chemicals Inc., Chicago, Illinois). Initiators are typically present in an amount of about 5% (w/w) or less. Because free-radical initiators do not become chemically a part of the polymers formed, the total amount of initiator is customarily not included when determining the amounts of other ingredients.
The device materials containing a UV absorber of the present invention preferably also contain a reactive colorant. Suitable reactive blue-light absorbing compounds include those described in U.S. Patent No. 5,470,932. Blue-light absorbers are typically present in an amount from about 0.01 - 0.5 % (weight).
IOLs constructed of the materials of the present invention can be of any design capable of being rolled or folded into a small cross section that can fit through a relatively smaller incision. For example, the IOLs can be of what is known as a one piece or multipiece design, and comprise optic and haptic components. The optic is that portion which serves as the lens. The haptics are attached to the optic and hold the optic in its proper place in the eye. The optic and haptic(s) can be of the same or different material. A multipiece lens is so called because the optic and the haptic(s) are made separately and then the haptics are attached to the optic. In a single piece lens, the optic and the haptics are formed out of one piece of material. Depending on the material, the haptics are then cut, or lathed, out of the material to produce the 1OL.
In addition to IOLs, the materials of the present invention are also suitable for use in other ophthalmic devices, such as contact lenses, keratoprostheses, and corneal inlays or rings.
The invention will be further illustrated by the following examples, which are intended to be illustrative, but not limiting.
EXAMPLE 1. Synthesis of 1,2,3-triazole functional polymerizable UV absorber [UV-1].
Figure imgf000011_0001
A 100 ml round bottom flask containing a PTFE coated stir bar is charged with 3.1Og of azido ethyl methacrylate (20 mmol), 2.36 g of o-hydroxyphenyl acetylene (20 mmol) and 50 mL of tetrahydrofuran. Copper turnings (1 g) were weighed and added. The flask was closed with a glass stopper and the reaction was stirred 48 h at ambient temperature. The copper was removed and the solvent was evaporated to yield product UV-1.
EXAMPLE 2. Synthesis of 1 ,2,3-triazole functional polymerizable UV absorber [UV-2].
Figure imgf000012_0001
A 100 ml round bottom flask containing a PTFE coated stir bar is charged with 5.09 g of 3-azido-2-azidomethyl-2-hydroxymethyl-propyl methacrylate (20 mmol), 2.36 g of o-hydroxyphenyl acetylene (20 mmol) and 50 ml_ of tetrahydrofuran. Copper turnings (1 g) are added and the solution is stirred for 48 h at ambient temperature. The copper was removed and the solvent was evaporated to yield product UV-2.
EXAMPLE 3. Synthesis of 1,2,3-triazole functional polymerizable UV absorber [UV-3].
Figure imgf000012_0002
A 100 ml round bottom flask containing a PTFE coated stir bar is flushed with N2 and charged with 2.48 g of propargyl methacrylate (20 mmol), 2.70 g of 2- azidophenol (20 mmol), 50 ml_ of N,N-dimethylformamide, 3.54 g of N1N1N1N", N"-pentamethyldiethylenetriamine, and 2.87 g of CuBr . The solution is stirred for 24 h at ambient temperature under a N2 blanket. The reaction mixture is then exposed to air and purified by passing through a chromatographic alumina column. The eluent is collected and the solvent is evaporated to yield product UV-3.
EXAMPLES 4 - 6. Copolymerization of 1,2,3-triazole functional polymerizable UV absorber. A vial is charged with ingredients as listed in Table 1 except for the initiator. The solution is mixed thoroughly and de-gassed by bubbling with N2. The initiator is added and the solution is again mixed thoroughly. The solution is filtered through a 0.2 micron PTFE filter and transferred to polypropylene molds. The molds are heated in a mechanical convection oven at 70 0C for 1 hr, then 110 0C for 2 hrs. The resulting copolymer samples are removed from the polypropylene molds and extracted in refluxing acetone for at least 3 hr, then rinsed with fresh acetone and allowed to air dry. The extracted polymer is dried under vacuum at 70 0C for at least 3 hr.
Table 1. Representative Copolymer Formulations
Amount (% w/w)
Ingredient 4 5 6
PEA 64.9 85.0 0.0
PEMA 30.0 0.0 0.0
PBMA 0.0 0.0 82.2
HEMA 0.0 15.0 0.0
PEG(IOOO)DMA 0.0 0.0 15.0 EGDMA 0.0 0.0 1.0
BDDA 3.2 3.2 0.0
UV absorber [UV-1] 1.8 1.8 1.8
methylphenylazo)-4- 0.1 0.0 0.0 hydroxyphenyljethyl methacrylamide
Perkadox®16S 1.0 1.0 1.0
PEA = 2-phenylethyl acrylate
PEMA = 2-phenylethyl methacrylate
PBMA = 4-phenylbutyl methacrylate
HEMA = 2-hydroxyethyl methacrylate
PEG(1000)DMA = polyethylene glycol (1000) dimethacrylate
EGDMA = ethylene glycol dimethacrylate
BDDA = 1 ,4-butanediol diacrylate
This invention has been described by reference to certain preferred embodiments; however, it should be understood that it may be embodied in other specific forms or variations thereof without departing from its special or essential characteristics. The embodiments described above are therefore considered to be illustrative in all respects and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description.

Claims

We claim:
1. A 1 ,4-disubstituted-1 ,2,3-triazole compound of the formula
■ N ' %
R1 where
Figure imgf000015_0001
Figure imgf000015_0002
x is 1 - 12;
Y is H, CH3, CH2OH, or CH3CH2;
Z is O, NH, N(CH3), or N(CH2CH3);
Z is O, NH, N(CH3), or N(CH2CH3); R" is H, F, Cl, Br, I, O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3,
CH(CHa)2, C(CHs)3, C6H5, or OC6H5; and
R'" is CH2=CH-, CH2=(CH3)-, or
provided that one, but not both,
Figure imgf000015_0003
of R and R' is
2. The 1,4-disubstituted-1,2,3-triazole compound of Claim 1 wherein the compound has the formula
Figure imgf000016_0001
[1] where in formula [1]
Ri u is, rxjok-
Figure imgf000016_0002
, or
Figure imgf000016_0003
x is 1 - 12;
YiSH1CH3, OrCH3CH2;
Z is O1 NH1 N(CH3), or N(CH2CH3); and
R2 is H, F, Cl, Br, I, O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3,
CH(CH3)2, C(CH3)3, C6H5, or OC6H5.
3. The 1 ,4-disubstituted-1 ,2,3-triazole compound of Claim 1 wherein the compound has the formula
Figure imgf000017_0001
[2] where in formula [2]
R3 is H, F, Cl, Br, I1 O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3,
CH(CH3)2l C(CH3)3, C6H5, or OC6H5;
Figure imgf000017_0002
x is 1 - 12;
Y iS H1 CH3, or CH3CH2; and
Z is O, NH, N(CH3), or N(CH2CH3).
4. The 1 ,4-disubstituted-1 ,2,3-triazole compound of Claim 1 wherein the compound has the formula
Figure imgf000017_0003
[3]
where in formula [3] R5 is CH2=CH-, CH2=C(CH3)-, or
Figure imgf000018_0001
R6 is H, F, Cl1 Br, I, O(CH2)XH, NH2, NH(CH3), N(CH3)2, CH3, CH2CH3, CH(CH3)2, C(CH3)3, C6H5, or OC6H5; x is 0-12;
Y iS H1 CH3, Or CH3CH2;
Z is O, NH, N(CH3), N(CH2CH3), or nothing; and
Z' is O, NH, N(CH3), N(CH2CH3), or nothing; provided that if x is O, then Z ≠ nothing and Z' = nothing.
5. An ophthalmic device material comprising the 1 ,4-disubstituted-1 ,2,3- triazole compound of Claim 1 and a device-forming monomer selected from the group consisting of acrylic monomers and silicone-containing monomers.
6. The ophthalmic device material of Claim 5 wherein the ophthalmic device material comprises from 0.1 to 5 % (w/w) of the 1 ,4-disubstituted-1 ,2,3- triazole compound of Claim 1.
7. The ophthalmic device material of Claim 6 wherein the ophthalmic device material comprises from 0.5 to 3 % (w/w) of the 1 ,4-disubstituted-1 ,2,3- triazole compound of Claim 1.
8. The ophthalmic device material of Claim 5 wherein the ophthalmic device material comprises a device-forming monomer of formula [IV]:
Figure imgf000018_0002
[IV] where in formula [IV]:
A is H, CH3, CH2CH3, or CH2OH; B is (CH2)m or [O(CH2)2]2; C is (CH2)W; m is 2 - 6; z is 1 - 10;
Y is nothing, O, S, or NR1, provided that if Y is O, S, or NR', then
B is (CH2)m;
R' is H, CH3, Cn >H2n'+1 (n'=1-10), iso-OC3H7, C6H5, or CH2CβH5; w is 0 - 6, provided that m + w <8; and
D is H, Ci - C4 alkyl, Ci - C4 alkoxy, C6H5, CH2C6H5 or halogen.
9. The ophthalmic device material of Claim 8 wherein in formula [IV]: A is H or CH3;
B is (CH2)m; m is 2 - 5;
Y is nothing or O; w is 0 - 1 ; and D is H.
10. The ophthalmic device material of Claim 9 wherein the ophthalmic device material comprises a monomer selected from the group consisting of: 2-phenylethyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-benzyloxyethyl methacrylate; and 3-benzyloxypropyl methacrylate; and their corresponding acrylates.
11. The ophthalmic device material of Claim 5 wherein the ophthalmic device material comprises a cross-linking agent.
12. The ophthalmic device material of Claim 5 wherein the ophthalmic device material comprises a reactive blue-light absorbing compound.
13. An intraocular lens comprising the 1 ,4-disubstituted-1 ,2,3-triazole compound of Claim 1.
14. An intraocular lens comprising the 1,4-disubstituted-1 ,2,3-triazole compound of Claim 2.
15. An intraocular lens comprising the 1 ,4-disubstituted-1 ,2,3-triazole compound of Claim 3.
16. An intraocular lens comprising the 1 ,4-disubstituted-1 ,2,3-triazole compound of Claim 4.
17. An ophthalmic device comprising the ophthalmic device material of Claim 5.
18. The ophthalmic device of Claim 18 wherein the ophthalmic device is selected from the group consisting of an intraocular lens; a contact lens; a keratoprosthesis; and a corneal inlay or ring.
PCT/US2008/061844 2007-04-30 2008-04-29 Uv-absorbers for ophthalmic lens materials WO2008134674A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE602008002426T DE602008002426D1 (en) 2007-04-30 2008-04-29 UV ABSORBER FOR GLASSES OF GLASSES
AU2008245533A AU2008245533B2 (en) 2007-04-30 2008-04-29 UV-absorbers for ophthalmic lens materials
JP2010506567A JP5273748B2 (en) 2007-04-30 2008-04-29 UV absorber for ophthalmic lens material
CA2683002A CA2683002C (en) 2007-04-30 2008-04-29 Uv-absorbers for ophthalmic lens materials
AT08747077T ATE479664T1 (en) 2007-04-30 2008-04-29 UV ABSORBER FOR GLASS LENS MATERIAL
EP08747077A EP2139871B1 (en) 2007-04-30 2008-04-29 Uv-absorbers for ophthalmic lens materials

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91492307P 2007-04-30 2007-04-30
US60/914,923 2007-04-30

Publications (1)

Publication Number Publication Date
WO2008134674A1 true WO2008134674A1 (en) 2008-11-06

Family

ID=39559880

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/061844 WO2008134674A1 (en) 2007-04-30 2008-04-29 Uv-absorbers for ophthalmic lens materials

Country Status (9)

Country Link
US (2) US7909458B2 (en)
EP (1) EP2139871B1 (en)
JP (1) JP5273748B2 (en)
AT (1) ATE479664T1 (en)
AU (1) AU2008245533B2 (en)
CA (1) CA2683002C (en)
DE (1) DE602008002426D1 (en)
ES (1) ES2349182T3 (en)
WO (1) WO2008134674A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009083457A1 (en) * 2007-12-28 2009-07-09 Basf Se Novel functionalized (meth)acrylic monomers and polymers from acetylenic alcohols
JP2010235928A (en) * 2009-03-09 2010-10-21 Sumitomo Chemical Co Ltd Polymer and method for producing polymer
WO2011069931A1 (en) 2009-12-09 2011-06-16 Basf Se Formulation of light-sensitive pesticides and comb polymers containing a uv absorber

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200916531A (en) * 2007-08-09 2009-04-16 Alcon Inc Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
TWI435915B (en) * 2007-08-09 2014-05-01 Alcon Inc Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light
EP2247976B1 (en) * 2008-02-12 2012-08-08 Aaren Scientific Inc. Ophthalmic lens having a yellow dye light blocking component
US7803359B1 (en) 2008-05-06 2010-09-28 Alcon, Inc. UV-absorbers for ophthalmic lens materials
US8043607B2 (en) 2008-07-15 2011-10-25 Novartis Ag UV-absorbers for ophthalmic lens materials
US8236053B1 (en) 2008-10-08 2012-08-07 Novartis Ag 2-amino benzophenone UV-absorbers for ophthalmic lens materials
TWI453199B (en) * 2008-11-04 2014-09-21 Alcon Inc Uv/visible light absorbers for ophthalmic lens materials
TWI464151B (en) * 2009-07-06 2014-12-11 Alcon Inc Uv/visible light absorbers for ophthalmic lens materials
US8993698B2 (en) * 2009-07-08 2015-03-31 Isp Investments Inc. 4- and 5 substituted 1,2,3-triazole moieties with at least one remote polymerizable moiety and polymers thereof
TW201311621A (en) 2011-08-15 2013-03-16 Novartis Ag UV-absorbers for ophthalmic lens materials
US8585938B1 (en) 2012-03-30 2013-11-19 Novartis Ag UV-absorbers for ophthalmic lens materials
CN106620893B (en) * 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 Materials for ocular disease phototherapy
CA3064161A1 (en) 2017-06-13 2018-12-20 Alcon Inc. Intraocular lens compositions
JP2019112533A (en) * 2017-12-24 2019-07-11 国立大学法人千葉大学 Copolymer that allows noble metal separation recovery, and noble metal recovery method using the copolymer
EP3894909A4 (en) 2018-12-10 2023-04-05 Seed Co., Ltd. Uv absorbing ocular lens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2099154A5 (en) * 1970-06-17 1972-03-10 Gaf Corp
US3880875A (en) * 1969-08-28 1975-04-29 Albert F Strobel Ultraviolet absorbing 2-(2-hydroxyphenyl) 2H-1,2,3-triazole derivatives
EP0989124A1 (en) * 1998-09-25 2000-03-29 Daicel Chemical Industries, Ltd. New polyester compounds having a benzotriazole group and a preparation method thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN139845B (en) * 1972-11-06 1976-08-07 Bayer Ag
DE3019521A1 (en) * 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING V-TRIAZOLE COMPOUNDS
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5331073A (en) 1992-11-09 1994-07-19 Allergan, Inc. Polymeric compositions and intraocular lenses made from same
US5470932A (en) 1993-10-18 1995-11-28 Alcon Laboratories, Inc. Polymerizable yellow dyes and their use in opthalmic lenses
JP3206004B2 (en) * 1995-06-07 2001-09-04 アルコン ラボラトリーズ， インコーポレイテッド Improved high refractive index ophthalmic lens materials
JPH09146244A (en) * 1995-11-21 1997-06-06 Konica Corp Image formation of silver halide photographic sensitive material
US6166218A (en) 1996-11-07 2000-12-26 Ciba Specialty Chemicals Corporation Benzotriazole UV absorbers having enhanced durability
JP4149068B2 (en) 1999-03-02 2008-09-10 株式会社メニコン Ophthalmic lens material
CN1151186C (en) 1999-09-07 2004-05-26 爱尔康通用有限公司 Foldable ophthalmic and otorhinolaryngological device materials
US20020042653A1 (en) 1999-11-23 2002-04-11 Copeland Victor L. Blue blocking intraocular lens implant
US6638991B2 (en) 2000-03-22 2003-10-28 Menicon Co., Ltd. Material for ocular lens
US6908978B2 (en) 2001-11-02 2005-06-21 Bausch & Lomb Incorporated High refractive index polymeric siloxysilane compositions
US6762271B2 (en) 2001-11-02 2004-07-13 Bausch & Lomb Incorporated High refractive index aromatic-based silyl monomers
EP2226316B1 (en) 2002-05-30 2016-01-13 The Scripps Research Institute Copper-catalysed ligation of azides and acetylenes
US6852793B2 (en) 2002-06-19 2005-02-08 Bausch & Lomb Incorporated Low water content, high refractive index, flexible, polymeric compositions
DK1521786T3 (en) 2002-07-16 2008-07-28 Alcon Inc Materials for ophthalmic and otorhinolaryngological devices
CA2512586A1 (en) 2003-01-09 2004-07-29 Alcon, Inc. Dual function uv-absorbers for ophthalmic lens materials
JP2005053058A (en) 2003-08-04 2005-03-03 Fuji Photo Film Co Ltd Optical information recording medium and information recording method
US6872793B1 (en) 2003-08-07 2005-03-29 Alcon, Inc. Ophthalmic and otorhinolaryngological device materials
EP1694721B1 (en) 2003-11-05 2013-10-09 Benz Research and Development Corporation Materials for making hydrophobic intraocular lens
JP4457030B2 (en) * 2004-02-26 2010-04-28 富士フイルム株式会社 Planographic printing plate precursor and lithographic printing plate manufacturing method
ATE549649T1 (en) 2004-11-22 2012-03-15 Abbott Medical Optics Inc COPOLYMERIZABLE AZONE COMPOUNDS AND ITEMS CONTAINING THEM
CN1727338A (en) 2004-12-27 2006-02-01 常州华钛化学有限公司 Compound in benzotriazole category possessing alkenyl ester type structure, and preparation method
US20060252850A1 (en) 2005-05-04 2006-11-09 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
EP1877840A4 (en) 2005-05-05 2010-05-19 Key Medical Technologies Inc Ophthalmic apparatuses and methods
US7842367B2 (en) 2005-05-05 2010-11-30 Key Medical Technologies, Inc. Ultra violet, violet, and blue light filtering polymers for ophthalmic applications
JP4636955B2 (en) * 2005-07-06 2011-02-23 キヤノン株式会社 Air processing apparatus and image forming system
US20070092830A1 (en) 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Polymeric radiation-absorbing materials and ophthalmic devices comprising same
US20070092831A1 (en) 2005-10-24 2007-04-26 Bausch & Lomb Incorporated Radiation-absorbing polymeric materials and ophthalmic devices comprising same
AU2007311172B2 (en) 2006-10-13 2013-01-31 Alcon Inc. Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics
ES2699166T3 (en) 2007-03-05 2019-02-07 Benz Res And Development Corporation Light filters that comprise a chromophore found in nature and its derivatives
JP2009013148A (en) 2007-07-03 2009-01-22 Shipro Kasei Kaisha Ltd Chemical modification to bis type structure by adipoyl dichloride, isophthaloyl dichloride or terephthaloyl dichloride of benzotriazole-based ultraviolet light absorbent having hydroxymethyl group
TWI435915B (en) * 2007-08-09 2014-05-01 Alcon Inc Ophthalmic lens materials containing chromophores that absorb both uv and short wavelength visible light

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880875A (en) * 1969-08-28 1975-04-29 Albert F Strobel Ultraviolet absorbing 2-(2-hydroxyphenyl) 2H-1,2,3-triazole derivatives
FR2099154A5 (en) * 1970-06-17 1972-03-10 Gaf Corp
EP0989124A1 (en) * 1998-09-25 2000-03-29 Daicel Chemical Industries, Ltd. New polyester compounds having a benzotriazole group and a preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009083457A1 (en) * 2007-12-28 2009-07-09 Basf Se Novel functionalized (meth)acrylic monomers and polymers from acetylenic alcohols
JP2010235928A (en) * 2009-03-09 2010-10-21 Sumitomo Chemical Co Ltd Polymer and method for producing polymer
WO2011069931A1 (en) 2009-12-09 2011-06-16 Basf Se Formulation of light-sensitive pesticides and comb polymers containing a uv absorber

Also Published As

Publication number Publication date
CA2683002C (en) 2014-05-20
CA2683002A1 (en) 2008-11-06
US20110105765A1 (en) 2011-05-05
EP2139871B1 (en) 2010-09-01
AU2008245533B2 (en) 2012-06-28
JP5273748B2 (en) 2013-08-28
AU2008245533A1 (en) 2008-11-06
US7909458B2 (en) 2011-03-22
US20080266519A1 (en) 2008-10-30
DE602008002426D1 (en) 2010-10-14
ES2349182T3 (en) 2010-12-28
EP2139871A1 (en) 2010-01-06
US8115009B2 (en) 2012-02-14
ATE479664T1 (en) 2010-09-15
JP2010526077A (en) 2010-07-29

Similar Documents

Publication Publication Date Title
EP2139871B1 (en) Uv-absorbers for ophthalmic lens materials
AU2008283862B2 (en) Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
US8262947B2 (en) UV/visible light absorbers for ophthalmic lens materials
US7781571B2 (en) Ophthalmic lens materials containing chromophores that absorb both UV and short wavelength visible light
WO2010053917A1 (en) Uv/visible light absorbers for ophthalmic lens materials
US8585938B1 (en) UV-absorbers for ophthalmic lens materials
WO2011005713A2 (en) Visible light absorbers for ophthalmic lens materials
US20100207068A1 (en) Process for producing purified synthesis gas from synthesis gas comprising trace amounts of sulphur contaminants with a metal-organic framework
EP2941419A1 (en) Uv-absorbers for ophthalmic lens materials
WO2013025671A1 (en) Uv-absorbers for ophthalmic lens materials

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08747077

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2683002

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2008747077

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008245533

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010506567

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2008245533

Country of ref document: AU

Date of ref document: 20080429

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12676475

Country of ref document: US